282 filings
8-K
IMNM
Immunome Inc
30 Apr 24
Departure of Directors or Certain Officers
4:01pm
4
Sandra M Swain
29 Apr 24
Immunome / SANDRA M SWAIN ownership change
8:14pm
3
Sandra M Swain
29 Apr 24
Immunome / SANDRA M SWAIN ownership change
8:12pm
ARS
2023 FY
IMNM
Immunome Inc
26 Apr 24
Annual report to shareholders
4:12pm
DEFA14A
IMNM
Immunome Inc
26 Apr 24
Additional proxy soliciting materials
4:08pm
8-K
w0if0j
25 Apr 24
Departure of Directors or Certain Officers
4:01pm
S-3ASR
jrkv 5a2hf78sb0po
3 Apr 24
Automatic shelf registration
4:40pm
S-3ASR
llpzbq 6iadz3xjhx47
3 Apr 24
Automatic shelf registration
4:36pm
8-K
wgh2qf ow5dv2dpgk4q
28 Mar 24
Immunome Reports Full-Year 2023 Financial Results and Provides Update on Recently Acquired Assets
4:04pm
8-K
vng0er qyl
26 Mar 24
Immunome Completes Acquisition of AL102, a Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala
8:05am
4
2qmjiu9atnzi
21 Feb 24
Immunome / Kinney Horn ownership change
9:10pm
3
bdfb5xyj87s4rfuc5
21 Feb 24
Immunome / Kinney Horn ownership change
9:07pm
8-K
zklcxzus5tmcb9j2l
14 Feb 24
Other Events
4:11pm
424B5
u493atbi
14 Feb 24
Prospectus supplement for primary offering
4:09pm
424B5
frhvd7
13 Feb 24
Prospectus supplement for primary offering
4:36pm
8-K
kq9nhkt
13 Feb 24
Results of Operations and Financial Condition
4:10pm
S-3ASR
mvwuftmt ej
13 Feb 24
Automatic shelf registration
4:04pm
SC 13G/A
gaq8gq
12 Feb 24
Immunome / Alpine Global Management ownership change
2:10pm